AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc.
Stay updated with breaking news from Spectrum Vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc.
AngioDynamics recently announced the sale of its PICC and Midline product portfolios to Spectrum Vascular for up to $45 million in cash.
Portfolio optimization enhances strategic focus and follows initiative to restructure manufacturing footprint Company to discontinue sales of radiofrequency ablation and Syntrax products ...
By Paul Ziobro AngioDynamics has sold its PICC and Midline product portfolios for up to $45 million in cash to Spectrum Vascular, as it slims down and...